Absolute neutrophil count by Duffy status among healthy Black and African American adults LE Merz, CM Story, MA Osei, K Jolley, S Ren, HS Park, ... Blood Advances 7 (3), 317-320, 2023 | 41 | 2023 |
Anticoagulation in cancer-associated thromboembolism with thrombocytopenia: a prospective, multicenter cohort study BJ Carney, TF Wang, S Ren, G George, A Al Homssi, M Gaddh, ... Blood advances 5 (24), 5546-5553, 2021 | 39 | 2021 |
Practice patterns and outcomes of direct oral anticoagulant use in myeloproliferative neoplasm patients J How, C Story, S Ren, D Neuberg, RP Rosovsky, GS Hobbs, JM Connors Blood Cancer Journal 11 (11), 176, 2021 | 19 | 2021 |
Visualizing, clustering, and characterizing activity-trip sequences via weighted sequence alignment and functional data analysis Y Song, S Ren, J Wolfson, Y Zhang, R Brown, Y Fan Transportation Research Part C: Emerging Technologies 126, 103007, 2021 | 16 | 2021 |
Phase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemia AA Lane, JS Garcia, EG Raulston, JL Garzon, I Galinsky, EW Baxter, ... Blood Advances 8 (3), 591-602, 2024 | 11 | 2024 |
Pulmonary hypertension is associated with poor cardiovascular and hematologic outcomes in patients with myeloproliferative neoplasms and cardiovascular disease O Leiva, S Ren, D Neuberg, A Bhatt, A Jenkins, R Rosovsky, R Karp Leaf, ... International Journal of Hematology 117 (1), 90-99, 2023 | 11 | 2023 |
Antiplatelet medications and risk of intracranial hemorrhage in patients with metastatic brain tumors EJ Miller, R Patell, EJ Uhlmann, S Ren, H Southard, P Elavalakanar, ... Blood Advances 6 (5), 1559-1565, 2022 | 11 | 2022 |
Influence of thrombocytopenia on bleeding and vascular events in atrial fibrillation V Iyengar, R Patell, S Ren, S Ma, A Pinson, A Barnett, P Elavalakanar, ... Blood Advances 7 (24), 7516-7524, 2023 | 8 | 2023 |
Outcomes after treatment of breast cancer during pregnancy including taxanes and/or granulocyte colony-stimulating factor use: findings from a multi-institutional retrospective … T Sella, P Exman, S Ren, TS Freret, KE Economy, WY Chen, HA Parsons, ... Breast Cancer Research and Treatment 194 (3), 597-606, 2022 | 8 | 2022 |
Pagophagia and restless legs syndrome are highly associated with iron deficiency and should be included in histories evaluating anemia MO Achebe, E Mandell, K Jolley, HS Park, R Freedman, S Ren, ... American Journal of Hematology 98 (1), E8-E10, 2023 | 7 | 2023 |
A randomized phase II study of metronomic cyclophosphamide and methotrexate (CM) with or without bevacizumab in patients with advanced breast cancer EL Mayer, N Tayob, S Ren, JJ Savoie, DR Spigel, HA Burris III, PD Ryan, ... Breast Cancer Research and Treatment 204 (1), 123-132, 2024 | 4 | 2024 |
Tagraxofusp in combination with azacitidine and venetoclax in newly diagnosed CD123+ acute myeloid leukemia, expansion cohort of a phase 1b multicenter trial AA Lane, JS Garcia, EG Raulston, JL Garzon, I Galinsky, EW Baxter, ... Blood 142, 4277, 2023 | 4 | 2023 |
Antiplatelet medications and intracranial hemorrhage in patients with primary brain tumors S Ma, R Patell, E Miller, S Ren, J Marquez-Garcia, S Panoff, R Sharma, ... Journal of Thrombosis and Haemostasis 21 (5), 1148-1155, 2023 | 4 | 2023 |
Feasibility of an online patient community to support older women with newly diagnosed breast Cancer RH Occhiogrosso, S Ren, N Tayob, T Li, HC Gagnon, A Paz, ... Clinical Breast Cancer 22 (2), 178-185, 2022 | 4 | 2022 |
Abstract PD7-03: translational breast cancer research consortium trial 022: neratinib and trastuzumab-emtansine for HER2+ breast cancer brain metastases (BCBM) R Freedman, S Ren, N Tayob, R Gelman, KL Smith, R Davis, A Pereslete, ... Cancer Research 83 (5_Supplement), PD7-03-PD7-03, 2023 | 3 | 2023 |
Bleeding risk in atrial fibrillation and thrombocytopenia: a propensity matched Cohort study V Iyengar, R Patell, S Ren, S Ma, A Pinson, A Barnett, P Elavalakanar, ... Blood 140 (Supplement 1), 345-346, 2022 | 3 | 2022 |
High incidence of bleeding found with direct oral anticoagulant use in myeloproliferative neoplasm patients CJ How, CMI Story, S Ren, DS Neuberg, RP Rosovsky, G Hobbs, ... Blood 138, 3632, 2021 | 3 | 2021 |
Pulmonary hypertension is associated with poor outcomes in patients with myeloproliferative neoplasms and cardiovascular disease O Leiva, S Ren, DS Neuberg, A Bhatt, A Jenkins, RP Rosovsky, RK Leaf, ... Blood 138, 3653, 2021 | 3 | 2021 |
Qualification of a multiplexed tissue imaging assay and detection of novel patterns of HER2 heterogeneity in breast cancer JL Guerriero, JR Lin, RG Pastorello, Z Du, YA Chen, MG Townsend, ... NPJ Breast Cancer 10 (1), 2, 2024 | 2 | 2024 |
Persistence of unequal access to classical hematology telemedicine visits by race and other demographics during the COVID-19 pandemic MA Osei, LE Merz, S Ren, DS Neuberg, M Achebe, JA Rodriguez, ... Telemedicine and e-Health 29 (8), 1266-1271, 2023 | 2 | 2023 |